Recommendations NCCN, SIOG, SoFOG, etc.
|
|
- Corey Andrews
- 6 years ago
- Views:
Transcription
1 Recommendations NCCN, SIOG, SoFOG, etc. Etienne Brain, MD, PhD Medical Oncology HÔPITAL RENÉ HUGUENIN Au 1 er janvier 2010, le Centre René Huguenin devient l Hôpital René Huguenin, un établissement de soins, d enseignement et de recherche de l Institut Curie
2 Guidelines Meta-Analyses Trials Evolving consensus Saint-Gallen NIH NCCN GEPOG/SoFOG
3 SIOG Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Aapro M, Bernard-Marty C, Brain E, et al. Ann Oncol. 2011;22: Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology: Droz JP, Balducci L, Bolla M, et al. BJU Int. 2010; 106:462-9 EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population. Pallis AG, Gridelli C, van Meerbeeck JP, et al. Ann Oncol 2010;21: Treatment t of the elderly l colorectal l cancer patient: t SIOG expert recommendations. Papamichael D, Audisio R, Horiot JC, et al. Ann Oncol 2009;20:5-16 The medical treatment of metastatic renal cell cancer in the elderly: Position paper of a SIOG Taskforce. Bellmunt J, Négrier S, Escudier E, et al. Crit Rev Oncol Hematol 2009;69:64-72 PACE participants, Audisio RA et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008;65: Wildiers H, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007;8: Lichtman SM, Wildiers H, Chatelut E, et al. International Society of Geriatric Oncology Chemotherapy Taskforce: Evaluation of chemotherapy in older patients - An analysis of the medical literature. J Clin Oncol 2007;25(May): Monfardini S, et al. Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force. Crit Rev Oncol Hematol 62:62-73, 2007 Launay-Vacher V, Chatelut E, et al. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations Ann Oncol 2007;18: Body JJ, Coleman R, Clezardin P et al. International ti society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients. Eur J Cancer 2007;43:852-8 Lichtman SM, et al. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer 43:14-34, 2007 Surbone A, et al., on behalf of the SIOG Task Force on Cultural Competence in the Elderly. The illness trajectory of elderly cancer patients across cultures: SIOG position paper. Ann Oncol 18:633-8, 2007 Extermann M, et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology. Crit Rev Oncol Hematol 55:241-52, 2005, 2007 Wedding U. Elderly patients have become the leading drug consumers: it's high time to properly evaluate new drugs within the real targeted population. J Clin Oncol 24:62-3, 2006 (no abstract available) Audisio RA et al. The surgical management of elderly cancer patients: recommendations of the SIOG Surgical Task Force. Eur J Cancer 40: , Repetto L, et al. Use of growth factors in the elderly patient with cancer: a report from the second International Society for Geriatric Oncology (SIOG) 2001 meeting. Crit Rev Oncol Hematol 45:123-8, 2003
4
5 G1 = fit No abnomaly CIRSG grade 2 (I)ADL normal MNA normal Standard treatment G2 vulnérable (reversible) CIRSG 1 grade 3 1 IADL Risk for denutrition 17 MNA < 24 Standard treatment ± geriatric intervention G3 fragile (non reversible) CIRSG 2 grade 3 or G4 1 grade 4 1ADL Severe denutrition MNA < 17 Cognitive impairement 15 < MMSE 24 Desorientation, confusion Symptomatic treatment ± specific actions Dependance, dementia Major comorbidities Terminal Palliative treatment
6
7
8 8
9 9
10 10
11 11
12 NCCN disease-specific Bladder Breast CNS CRC H&N Kidney MM NSCLC Prostate t
13 GEPOG/SoFOG Metastatic CRC Fit: local treatment for A taste of "CGA» liver M+ whenever Patient involvement possible with preop chemo; clinical trials Social measures + denutrition / comorbidities Intermediate: radiofrequency; evaluate potential resection w/ preop assessment; monochemo Fragile: symptomatic treatment
14 National French Recommendations for Chemotherapy Summary of previous recommendations Validated regimens 4 AC 6CMF Options: TC 4 TC > 4 AC Post hoc sub group analysis in a randomized trial, n ~ 80 Sequential regimen No data Reassuring data for safety profile of TC MC (liposomal doxorubicin) grade B grade C Systematically discuss primary prophylaxis w/ GCSF expert agreement 14
Optimal chemotherapy regimen. for older women with breast cancer
Optimal chemotherapy regimen and targeted treatments for older women with breast cancer Etienne Brain, MD, PhD Medical Oncology HÔPITAL RENÉ HUGUENIN Au 1 er janvier 2010, le Centre René Huguenin devient
More informationDifferent adjuvant chemotherapy regimens in older breast cancer patients?
Annals of Oncology Advance Access published January 18, 2015 1 Different adjuvant chemotherapy regimens in older breast cancer patients? Hans Wildiers 1 and Etienne Brain 2 1Department of General Medicine,
More informationGeriatric screening tools in older patients with cancer
Geriatric screening tools in older patients with cancer Pr. Elena Paillaud Henri Mondor hospital, Créteil, France University Paris-Est Créteil CONFLICT OF INTEREST DISCLOSURE I have the following potential
More informationBreast cancer in elderly
Breast cancer in elderly IBDC Feb 6, 2013 Etienne Brain, MD, PhD Medical Oncology HÔPITAL RENÉ HUGUENIN Au 1 er janvier 2010, le Centre René Huguenin devient l Hôpital René Huguenin, un établissement de
More informationComunication and Information modality among elderly patients
Comunication and Information modality among elderly patients 8th annual SIOG meeting, Madrid Nov 9th and Nov 10th, 2007 Lazzaro Repetto U.O. Oncologia - INRCA, IRCCS, Rome European Survival Data total
More informationAdjuvant chemotherapy in older breast cancer patients: how to decide?
Adjuvant chemotherapy in older breast cancer patients: how to decide? H. Wildiers University Hospitals Leuven Belgium Wildiers H, Kunkler I, Lancet Oncol 2007 Biganzoli L, Wildiers H, Lancet Oncol. 2012
More informationBreast Cancer in the Elderly Systemic Adjuvant Therapy & Genomic Tools
Breast Cancer in the Elderly Systemic Adjuvant Therapy & Genomic Tools Etienne GC Brain, MD PhD Hôpital René Huguenin / Institut Curie Saint-Cloud, France Breast Ovary De Angelis Lancet Oncol 2013 Current
More informationUse of Taxanes in Older Breast Cancer Patients
SIOG Guidelines Update 2014: Use of Taxanes in Older Breast Cancer Patients Laura Biganzoli Medical Oncology Dept New Hospital of Prato Istituto Toscano Tumori Italy Fundamental steps Task Force (TF) on
More informationMatti S. Aapro Genolier Cancer Center Switzerland
Matti S. Aapro Genolier Cancer Center Switzerland The role of SIOG International Society of Geriatric Oncology IMPROVING THE EVIDENCE-BASE FOR TREATING OLDER ADULTS WITH CANCER Work of SIOG and its members
More informationMeet the Professor Dosing and toxicity management
Meet the Professor Dosing and toxicity management Lodovico Balducci & Catherine Terret Mrs. Marie O. 78 years Right breast tumor : 50 mm, upper outer quadrant, Node: 0 Biopsy (9 Dec 2009) Invasive ductal
More informationAnthracyclines in the elderly breast cancer patients
Anthracyclines in the elderly breast cancer patients Etienne GC Brain, MD PhD Medical Oncology Centre René Huguenin, Saint-Cloud & Group GERICO, FNCLCC, Paris Centre René Huguenin - Saint-Cloud Facts about
More informationUpdate of the clinical trials for the
SIOG 2008 16th-18th October 2008 in Montreal Update of the clinical trials for the elderly European / EORTC Perspective e Ulrich Wedding Universitätsklinikum Jena Chair of the Task Force Cancer in the
More informationETHICAL CONSIDERATIONS IN CLINICAL TRIALS IN THE ELDERLY
ETHICAL CONSIDERATIONS IN CLINICAL TRIALS IN THE ELDERLY Antonella Surbone,, MD PhD FACP New York University SIOG 8 International Congress, Madrid, 8-10 November 2007 Ethics does not treat of the world.
More informationCaring for the Older Patient with Cancer in the Primary Care Setting. Janine Overcash, PhD, GNP-BC. University of South Florida
Caring for the Older Patient with Cancer in the Primary Care Setting Janine Overcash, PhD, GNP-BC University of South Florida jovercas@health.usf.edu (813) 727-7277 cell phone Objectives At the end of
More informationWhat is New in Geriatric Oncology: The Medical Oncology Perspective. Arti Hurria, MD Director, Cancer and Aging Research Program City of Hope
What is New in Geriatric Oncology: The Medical Oncology Perspective Arti Hurria, MD Director, Cancer and Aging Research Program City of Hope Cancer Incidence in the U.S. Between 2010 and 2030, cancer incidence
More informationComprehensive Geriatric Assesment (CGA) In Older Patients with Malignant Hemopathies
BHSSeminar#7 Generalskills Comprehensive Geriatric Assesment (CGA) In Older Patients with Malignant Hemopathies Prof.&&&Dominique&&BRON& Inst.&J.&Bordet&&7&ULB& 24th&of&May&2014& 1 WHY WHEN HOW WhyCGA?!
More informationPaul Calabresi Award. From suboptimal to optimal treatment in older patients with cancer. Pierre Soubeyran, MD, PhD
Paul Calabresi Award From suboptimal to optimal treatment in older patients with cancer Pierre Soubeyran, MD, PhD Institut Bergonié, Université Bordeaux Segalen Health status-adapted cancer care Balance
More informationAntracyclines et sujet âgé
Antracyclines et sujet âgé Etienne GC Brain, MD PhD Medical Oncology Hôpital René Huguenin / Institut Curie Saint-Cloud, France www.siog.org Facts about anthracyclines Cornerstone for treatment of MBC
More informationSIOG Presidential Session. Chair Arti Hurria, SIOG President
SIOG Presidential Session Chair Arti Hurria, SIOG President 2012-2014 Presidential Address Etienne Brain, SIOG President 2014-2016 SIOG 2014-2016 Etienne GC Brain, MD PhD Medical Oncology Hôpital René
More informationAdjuvant Chemotherapy for Elderly Women with Breast Cancer: Matti S. Aapro, M.D. IMO Clinique de Genolier Switzerland
SIOG Berlin October 2009 Adjuvant Chemotherapy for Elderly Women with Breast Cancer: Immediate Benefit and Long-Term Risk Matti S. Aapro, M.D. IMO Clinique de Genolier Switzerland 1 2 BACKGROUND MESSAGE
More informationGeriatric Assessment to Improve Outcomes for Older Adults with Cancer
Geriatric Assessment to Improve Outcomes for Older Adults with Cancer Allison Magnuson, DO Assistant Professor of Medicine University of Rochester Medical Center Objectives Appreciate the demographics
More informationOvarian cancer in elderly women
Ovarian cancer Ovarian cancer in elderly women Claire FALANDRY, Michel FABBRO, Olivier GUERIN, Jean-Emmanuel KURTZ, Anne LESOIN. Problem Background Population on the rise and extremely heterogeneous Delayed
More informationCARDIOVASCULAR CONSIDERATIONS IN THE GERIATRIC PATIENT WITH CANCER
CARDIOVASCULAR CONSIDERATIONS IN THE GERIATRIC PATIENT WITH CANCER MARTINE EXTERMANN, MD, PHD MOFFITT CANCER CENTER, UNIVERSITY OF SOUTH FLORIDA TAMPA, FL, USA JEOPARDY CATEGORIES Age as a risk factor
More informationThe Role that Geriatricians Can Play in the Care of Older Patients with Cancer Across the Care Continuum
The Role that Geriatricians Can Play in the Care of Older Patients with Cancer Across the Care Continuum Holly M. Holmes, MD, MS Associate Professor and Division Director Geriatric and Palliative Medicine
More informationTo treat or not to treat: When to treat! A case presentation
To treat or not to treat: When to treat! A case presentation Filip Ameye, MD,Phd Universitary Hospitals Leuven, Belgium Departement of Urology Prostate Center A case presentation Pt. 76 y. Mild LUTS (07/1999)
More informationBreast cancer (screening) in older individuals: the oncologist s viewpoint for the geriatrician
Breast cancer (screening) in older individuals: the oncologist s viewpoint for the geriatrician Hans Wildiers Medical oncologist, Leuven, Belgium Past chairman of the EORTC elderly task force President-elect
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
More informationDevelopment of Geriatric Oncology in France
Development of Geriatric Oncology in France Pr Pierre Soubeyran Institut Bergonié, Bordeaux, France Epidemiology French population, 2013 9% older than 75 (10.9% females, 7% males) Number of cancer cases
More information22th March Endpoints and their relevance to older people: Cancer and Palliative Care and work of EORTC. Ulrich Wedding
22th March 2012 Endpoints and their relevance to older people: Cancer and Palliative Care and work of EORTC Elderly Task Force EORTC, Brussels University of Jena, Germany Department of Palliative Care
More informationAre the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium
Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium Clinical practice guidelines Definition > Systemically developed statements
More informationSponsor: Currently there are not sponsorships. For More Information:
Dipartimento di Geriatria, Neuroscienze ed Ortopedia SOCIETÀ ITALIANA DI GERONTOLOGIA E GERIATRIA ADVANCED COURSE IN GERIATRIC ONCOLOGY Under the auspicies of SIOG (International Society of Geriatric Oncology),
More informationPerformance of Four Frailty Classifications in Older Patients With Cancer: Prospective Elderly Cancer Patients Cohort Study
JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Performance of Four Frailty Classifications in Older Patients With Cancer: Prospective Elderly Cancer Patients Cohort Study Emilie Ferrat, Elena
More informationUvA-DARE (Digital Academic Repository) Decision making in geriatric oncology Hamaker, M.E. Link to publication
UvA-DARE (Digital Academic Repository) Decision making in geriatric oncology Hamaker, M.E. Link to publication Citation for published version (APA): Hamaker, M. E. (202). Decision making in geriatric oncology
More informationOrganization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force
Critical Reviews in Oncology/Hematology 62 (2007) 62 73 Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force Silvio Monfardini
More informationCancer Treatment in Elderly Patients. Greg Hart Clinical Oncologist GVI Oncology
Cancer Treatment in Elderly Patients Greg Hart Clinical Oncologist GVI Oncology Ovarian Cancer Cervical Cancer Uterine Cancer Cancer in the Elderly 59% of all cancers occur in over 65 s, 30% in over
More informationProblems related to the management of malignant hemopathies in older patients
Problems related to the management of malignant hemopathies in older patients Dr Marie Maerevoet Gent, 25 January 2013 BHS satellite symposium on Elderly Malignant Hemopathies in older patients - 33% of
More informationChanges in the use of end points in clinical trials for elderly cancer patients over time
Annals of Oncology 28: 2606 2611, 2017 doi:10.1093/annonc/mdx354 Published online 3 August 2017 ORIGINAL ARTICLE Changes in the use of end points in clinical trials for elderly cancer patients over time
More informationRehabilitation of the Older Cancer Patient. Lodovico Balducci, M.D. Moffitt Cancer Center Tampa, Florida
Rehabilitation of the Older Cancer Patient Lodovico Balducci, M.D. Moffitt Cancer Center Tampa, Florida Rehabilitation of the older cancer patient Is cancer treatment effective in older individuals? Chronologic
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited
More informationQuestionnaires and instruments for a multidimensional assessment of the older cancer patient: What clinicians need to know?
E U R O P E A N J O U R N A L O F CA N C E R46 (2010) 1019 1025 available at www.sciencedirect.com journal homepage: www.ejconline.com Review Questionnaires and instruments for a multidimensional assessment
More informationClinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients
https://doi.org/10.1007/s10147-018-01385-8 ORIGINAL ARTICLE Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients Satoko Ito 1 Haruyuki Ito 2 Noriyuki
More informationCommunicating Treatment Options to Older Patients: Challenges and Opportunities
Communicating Treatment Options to Older Patients: Challenges and Opportunities Arti Hurria, MD Director, Cancer and Aging Research Program City of Hope National Medical Center Duarte, California, USA
More informationEvolving Insights into Adjuvant Chemotherapy. Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology US Oncology
Evolving Insights into Adjuvant Chemotherapy Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology US Oncology 80 70 60 50 40 30 20 10 0 EBCTCG 2005/6 Overview Control Arms with No Systemic
More informationClinical Trials. Ovarian Cancer
1.0 0.8 0.6 0.4 0.2 0.0 < 65 years old 65 years old Events Censored Total 128 56 184 73 35 108 0 12 24 36 48 60 72 84 27-10-2012 Ovarian Cancer Stuart M. Lichtman, MD Attending Physician 65+ Clinical Geriatric
More informationHow many and which items of activities of daily living (ADL) and instrumental activities of daily living (IADL) are necessary for screening
Critical Reviews in Oncology/Hematology 62 (2007) 164 171 Contents How many and which items of activities of daily living (ADL) and instrumental activities of daily living (IADL) are necessary for screening
More informationDr. Joyita Banerjee PhD Scholar Dept. of Geriatric Medicine AIIMS, New Delhi, India
IMPORTANCE OF COMPREHENSIVE GERIATRIC ASSESSMENT IN CANCER IN ELDERLY AN INDIAN PERSPECTIVE Dr. Joyita Banerjee PhD Scholar Dept. of Geriatric Medicine AIIMS, New Delhi, India INTRODUCTION - Cancer in
More informationAssessing older patients with hematological malignancies
Assessing older patients with hematological malignancies Alfonso J. Cruz Jentoft Servicio de Geriatría Hospital Universitario Ramón y Cajal Madrid, Spain Is old = frail? 45 days old 2,000 years old 4,600
More informationThe DATECAN initiative
The DATECAN initiative Definition and Assessment of Time-to-event Endpoints in CANcer trials Carine BELLERA INSERM U1219 et Institut Bergonié, Bordeaux On behalf of the DATECAN steering committee Genesis
More informationJ Clin Oncol 30: by American Society of Clinical Oncology INTRODUCTION
VOLUME 3 NUMBER 2 JANUARY 1 212 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/ Vinblastine in Patients
More informationADVANCES IN THE FIELD. Matti S. Aapro IMO Genolier Switzerland
2d Asian meeting ADVANCES IN THE FIELD Matti S. Aapro IMO Genolier Switzerland COI Dr Aapro is a consultant for Amgen, BMS, Celgene, GSK, Helsinn, JnJ Novartis, Merck, Merck Serono, Pfizer, Pierre Fabre,
More informationManagement of Advanced Colorectal Cancer in Older Patients
Review Article [1] April 15, 2005 By Stuart M. Lichtman, MD, FACP [2] Many elderly individuals have substantial life expectancy, even in the setting of significant illness. There is evidence to indicate
More informationDISCLOSURES LEARNING OBJECTIVES DEFINITIONS
GERIATRIC ONCOLOGY: AN OVERVIEW OF CONSIDERATIONS IN OLDER ADULTS RECEIVING CANCER TREATMENT Mark Pasetka Clinical Pharmacy Coordinator Odette Cancer Centre Sunnybrook Health Sciences Centre 27 April 2019
More informationIdeal neo-adjuvant Chemotherapy in breast ca. Dr Khanyile Department of Medical Oncology, University of Pretoria
Ideal neo-adjuvant Chemotherapy in breast ca Dr Khanyile Department of Medical Oncology, University of Pretoria When is neo-adjuvant Chemo required? Locally advanced breast ca: - Breast conservative surgery
More informationMedical treatment of metastatic renal cell carcinoma (mrcc) in the elderly ( 65y): Position of a SIOG Taskforce
Medical treatment of metastatic renal cell carcinoma (mrcc) in the elderly ( 65y): Position of a SIOG Taskforce Medical treatment of metastatic RCC in the elderly ( 65y): Members of the SIOG Taskforce
More informationChemotherapy for older patients with prostate cancer
Mini rev Article AGE AND CHEMOTHERAPY IN PROSTATE CANCER ANDERSON et al. Chemotherapy for older patients with prostate cancer John Anderson, Hein Van Poppel*, Joaquim Bellmunt, Kurt Miller, Jean-Pierre
More informationA mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study
Critical Reviews in Oncology/Hematology 77 (2011) 63 69 A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study Thomas Aparicio a,c,, Laurence Girard
More informationAdjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: Results of an observational study
Critical Reviews in Oncology/Hematology 80 (2011) 466 473 Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: Results of an observational study Gilles Freyer a,b,, Mario Campone
More informationBOTH the incidence and mortality of cancer increase
Journal of Gerontology: MEDICAL SCIENCES 2008, Vol. 63A, No. 5, 518 522 Copyright 2008 by The Gerontological Society of America Usefulness of Frailty Markers in the Assessment of the Health and Functional
More informationJefferson In the News!
Evaluation of a Pharmacist-led Medication Assessment to Identify the Prevalence of Polypharmacy and Potentially Inappropriate Medication (PIM) Use Among Ambulatory Seniors with Cancer Ginah Nightingale,
More informationL.-X. Wang 1,5,6, Z.M. Meng 1,6, S.S. Nie 1, B. Xiang 2, J. Li 1, Q.Q. Sun 1, H. Qin 1, Y.L. Gong 3, C.C. Pan 1, C.Yi 3, Y.X. Yang 5, S.
Journal of Aging Research & Clinical Practice Volume 4, Number 4, 2015 J Aging Res Clin Practice 2015;4(4):190-196 Published online December 2, 2015, http://dx.doi.org/10.14283/jarcp.2015.71 WHAT ARE THE
More informationAmsterdam, The Netherlands. Key Words. Comprehensive geriatric assessment Prognostication Elderly Treatment tolerance
The Oncologist Geriatric Oncology The Value of Geriatric Assessments in Predicting Treatment Tolerance and All-Cause Mortality in Older Patients With Cancer MARIJE E. HAMAKER, a ALINDA G. VOS, b CAROLIEN
More informationConsiderations in Adjuvant Chemotherapy. Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology US Oncology
Considerations in Adjuvant Chemotherapy Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology US Oncology 80 70 60 50 40 30 20 10 0 EBCTCG 2005/6 Overview Control Arms with No Systemic Treatment
More informationClinical Management Guideline for Breast Cancer
Initial Evaluation Clinical Stage Pre-Treatment Evaluation Treatment and pathological stage Adjuvant Treatment Less than 4 positive lymph nodes ER Positive HER2 Negative (see page 2 & 3 ) Primary Diagnosis:
More informationRecherche Clinique en Oncogériatrie
Recherche Clinique en Oncogériatrie Dr Etienne GC Brain Oncologie Médicale Hôpital René Huguenin / Institut Curie Saint-Cloud, France www.siog.org 8842 studies found for: Open Studies Interventional Studies
More informationOvercoming challenges associated with chemotherapy treatment in the senior adult population
Critical Reviews in Oncology/Hematology 68S (2008) S1 S8 Overcoming challenges associated with chemotherapy treatment in the senior adult population Jean-Pierre Droz a,, Matti Aapro b, Lodovico Balducci
More informationANTIEMETICS and FEBRILE NEUTROPENIA. Matti S. Aapro Genolier Switzerland
ANTIEMETICS and FEBRILE NEUTROPENIA Matti S. Aapro Genolier Switzerland 2010 Multinational Association of Supportive Care in Cancer TM All rights reserved worldwide. Disclosures Collaborations in this
More informationUICC EML Review 2014
UICC EML Review 2014 Granulocyte Stimulating Agents (G- CSF) Supplemental Document Many antineoplastic agents are cytotoxic to the bone marrow and prevent the development of granulocytes necessary to fight
More informationTreatment of the elderly patient with mantle cell lymphoma
MANTLE CELL LYMPHOMA Treatment of the elderly patient with mantle cell lymphoma Pierre Soubeyran 1 and Rémy Gressin 2 1 Department of Medical Oncology, Institut Bergonié, Bordeaux, France; and 2 Department
More informationClinical Impact of primary prophylaxis for FN in breast cancer patients. Prof. Young Jin Suh The Catholic University of Korea
Clinical Impact of primary prophylaxis for FN in breast cancer patients Prof. Young Jin Suh The Catholic University of Korea Objectives Describe the prevalence of febrile neutropenia in patients with breast
More informationApproach to Decision Making in Older Patients with Cancer
Approach to Decision Making in Older Patients with Cancer Toni Pacioles, MD Assistant Professor Hematology and Medical Oncology Joan C. Edwards School of Medicine at Marshall University Overview Cancer
More informationUnderstanding and meeting the needs of the older population: Acknowledgements. The Shifting Face of Health Care
Understanding and meeting the needs of the older population: a global l challenge Howard Bergman, MD Jewish General Hospital/ Montréal, Canada www.solidage.ca Groupe de recherche Université de Montréal/
More informationComorbidities in Multiple Myeloma
Comorbidities in Multiple Myeloma Michel Delforge, MD, PhD University Hospital Leuven Leuven, Belgium COMy, Bangkok 12 may 2014 Comy Meeting, Bangkok, 12 may 2014 Disclosures Advisory board: Janssen,
More informationTreating Advanced Breast Cancer in the Older Woman
Review Article [1] October 01, 2006 By Martine Extermann, MD, PhD [2] As half of all breast cancers occur in patients beyond the age of 65 and a quarter beyond the age of 75, a significant number of patients
More informationComorbidities and cancer Applications to non small cell lung cancer
Comorbidities and cancer Applications to non small cell lung cancer Pr A. Vergnenègre Dr H. Le Caer CHU Limoges CH Draguignan 1 Comorbidities and cancer Why? 2 Epidemiology elderly among lung cancer 2010-2014
More informationAC-DOCE Regimen. AC-DOCE+TRAS Regimen AC-DOCE AC-DOCE+TRAS. A - Regimen Name. Disease Site Breast. Adjuvant. Regimen Category. Evidence-Informed :
Regimen Monograph Regimen Name Drug Regimen Cycle Frequency Premedication and Supportive Measures Dose Modifications Adverse Effects Interactions Drug Administration and Special Precautions Recommended
More informationTJ ISSN Introduction SHORT COMMUNICATION
TJ ISSN 0300-8916 Tumori 2017; 103(1): e4-e8 DOI: 10.5301/tj.5000543 SHORT COMMUNICATION Efficacy and safety of vinorelbine-capecitabine oral metronomic combination in elderly metastatic breast cancer
More informationLow-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer
Med Oncol (2014) 31:870 DOI 10.1007/s12032-014-0870-2 ORIGINAL PAPER Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer Jasmine Miger Annika Holmqvist Xiao-Feng Sun Maria Albertsson
More informationLocally Advanced NSCLC and its management in the Elderly. Dr Laura Pemberton Consultant Clinical Oncologist, Christie Hospital, UK
Locally Advanced NSCLC and its management in the Elderly Dr Laura Pemberton Consultant Clinical Oncologist, Christie Hospital, UK Topics covered Concurrent Chemoradiotherapy (concrt) in elderly Radiotherapy
More informationDiagnosis and Treatment of Breast Cancer in the Elderly
CA Cancer J Clin 2003;53:227 244 Diagnosis and Treatment of Breast Cancer in the Elderly Chris E. Holmes MD, PhD; Hyman B. Muss, MD ABSTRACT As the population of the United States ages, women over the
More informationMultigene Testing in NCCN Breast Cancer Treatment Guidelines, v1.2011
Multigene Testing in NCCN Breast Cancer Treatment Guidelines, v1.2011 Robert W. Carlson, M.D. Professor of Medicine Stanford University Chair, NCCN Breast Cancer Treatment Guidelines Panel Selection of
More informationIs the Neo-adjuvant Approach Better than Adjuvant Approach? Comparative Levels of Evidence: Randomized Trials
Is the Neo-adjuvant Approach Better than Approach? Virginie Westeel University Hospital Besançon, France Perspectives in Lung Cancer Amsterdam, 5-6 March 2010 Comparative Levels of Evidence: Randomized
More informationInitial hormone therapy (and more) for metastatic prostate cancer
Initial hormone therapy (and more) for metastatic prostate cancer Silke Gillessen, MD Medical Oncology Kantonsspital St.Gallen Switzerland silke.gillessen@kssg.ch Conflicts of interest Speakers Bureau
More informationIntroduction. Wilfred Truin 1 Rudi M. H. Roumen. Vivianne C. G. Tjan-Heijnen 2 Adri C. Voogd
Breast Cancer Res Treat (2017) 164:133 138 DOI 10.1007/s10549-017-4220-x EPIDEMIOLOGY Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients
More informationMonitor G-CSF Study Treatment patterns and outcomes in the prophylaxis of chemotherapy induced neutropenia with biosimilar filgrastim (Zarzio )
Monitor G-CSF Study Treatment patterns and outcomes in the prophylaxis of chemotherapy induced neutropenia with biosimilar filgrastim (Zarzio ) Heinz Ludwig Wilhelminen Cancer Research Institute c/o I
More informationUvA-DARE (Digital Academic Repository) Decision making in geriatric oncology Hamaker, M.E. Link to publication
UvA-DARE (Digital Academic Repository) Decision making in geriatric oncology Hamaker, M.E. Link to publication Citation for published version (APA): Hamaker, M. E. (2012). Decision making in geriatric
More informationExiste-t-il un sous groupe à risque qui pourrait bénéficier d une modification de la durée de traitement par trastuzumab? X. Pivot CHRU De Besançon
Existe-t-il un sous groupe à risque qui pourrait bénéficier d une modification de la durée de traitement par trastuzumab? X. Pivot CHRU De Besançon In 25 results of 4 Adjuvant Herceptin trials have definitively
More informationUvA-DARE (Digital Academic Repository) Decision making in geriatric oncology Hamaker, M.E. Link to publication
UvA-DARE (Digital Academic Repository) Decision making in geriatric oncology Hamaker, M.E. Link to publication Citation for published version (APA): Hamaker, M. E. (2012). Decision making in geriatric
More informationOncologist. The. Geriatric Oncology
The Oncologist Geriatric Oncology The Value of Geriatric Assessments in Predicting Treatment Tolerance and All-Cause Mortality in Older Patients with Cancer MARIJE E. HAMAKER, a ALINDA G. VOS, b CAROLIEN
More informationEarly Involvement of Palliative Care. Jessica Heestand, PGY2 5/14/2014
Early Involvement of Palliative Care Jessica Heestand, PGY2 5/14/2014 Why is this important? Palliative care is frequently misconstrued as synonymous with end-of-life care Palliative care is important
More informationPre- Cardiac intervention. Dr. Victor Sim 26 th Sept 2014
Pre- Cardiac intervention Frailty assessment Dr. Victor Sim 26 th Sept 2014 Defining frailty Lacks consensus (Rockwood CMAJ 2005;173(5):489-95 Introduction) Some consider symptoms, signs, diseases and
More informationBreast Cancer Breast Managed Clinical Network
Initial Evaluation Clinical Stage Pre-Treatment Evaluation Treatment and pathological stage Less than 4 positive lymph nodes Adjuvant Treatment ER Positive HER2 Negative (see page 2 & 3 ) HER2 Positive
More informationReference No: SG 23/13
Title: Author(s) Ownership: Approval by: Guidelines for the use of granulocyte colony stimulating factor (GSCF) in adult oncology & malignant haematology patients Paula Scullin, Consultant Medical Oncologist,
More informationPolicy. Medical Policy Manual Approved Revised: Do Not Implement Until 3/2/19. Nivolumab (Intravenous)
Nivolumab (Intravenous) NDC CODE(S) 00003-3772-XX Opdivo 40 MG/4ML SOLN (B-M SQUIBB U.S. (PRIMARY CARE)) 00003-3774-XX Opdivo 100 MG/10ML SOLN (B-M SQUIBB U.S. (PRIMARY CARE)) 00003-3734-XX Opdivo 240
More informationSteven Jubelirer, MD Clinical Professor Medicine WVU Charleston Division Senior Research Scientist CAMC Research Institute
Steven Jubelirer, MD Clinical Professor Medicine WVU Charleston Division Senior Research Scientist CAMC Research Institute Objectives Develop a systematic way to think about benefits and harms of cancer
More informationLancet 2008; 372 : CDF. N Engl J Med Aug 28;349(9): J Clin Oncol May 15;19(10): Cancer Nov 1;113(9):2471-7
Tumour Group: UROLOGY Renal Palliative Sunitinib 1 st line therapy Lancet. 1999 Jan 2;353(9146):14-7. Pazopanib 1 st line therapy J Clin Oncol. 2010 28(06):1061-1068 Everolimus 2 nd or 3 rd line in adv./metas.rcc
More informationChemotherapy feasibility in older patients with metastatic bladder cancer: A multicenter cohort study AGEVIM
Chemotherapy feasibility in older patients with metastatic bladder cancer: A multicenter cohort study AGEVIM Laurent M, Brureau L, El Demery M, Fléchon A, Le Thuaut A, Carvahlo-Verlinde M, Bastuji-Garin
More informationTristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease
Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Jennifer E. Tseng, MD UFHealth Cancer Center-Orlando Health Sep 12, 2014 Background Approximately
More informationCommon disease 175,000 new cases/year 44,000 deaths/year Less than 10% with newly diagnosed at presentation have stage IV disease Chronic disease,
Chemotherapy for Metastatic Breast Cancer: Recent Results HARMESH R. NAIK, MD. Karmanos Cancer Institute and St. Mary Hospital Metastatic breast cancer (MBC) Common disease 175,000 new cases/year 44,000
More informationAdjuvant Chemotherapy
State-of-the-art: standard of care for resectable NSCLC Adjuvant Chemotherapy JY DOUILLARD MD PhD Professor of Medical Oncology Integrated Centers of Oncology R Gauducheau University of Nantes France Adjuvant
More informationCo-ordinating care through multidisciplinary working
Co-ordinating care through multidisciplinary working Shane O Hanlon Consultant, Elderly Care Medicine (Surgical Liaison & Oncogeriatrics) Kay Hargreaves Macmillan Occupational Therapist Case Mrs Jones
More information